| A Study of IBI363 in Subjects With Advanced Malignancies (NCT06468098) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-06-15 |
| A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors (NCT06394713) | Qilu Pharmaceutical Co., Ltd. | 2024-06-15 |
| F01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus (NCT06468683) | Shanghai Simnova Biotechnology Co.,Ltd. | 2024-06-15 |
| In-office Repair of Chronic Tympanic Membrane Perforations (NCT06448039) | D. Bradley Welling, MD, PhD | 2024-06-15 |
| IBRX-042 In Participants With HPV-Associated Tumors (NCT05976828) | ImmunityBio, Inc. | 2024-06-14 |
| A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma (NCT06574568) | Excyte Biopharma Ltd | 2024-06-14 |
| A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma (NCT06342908) | Jonsson Comprehensive Cancer Center | 2024-06-14 |
| PTCy and ATG for MSD and MUD Transplants (NCT06299462) | Instituto Nacional de Cancer, Brazil | 2024-06-14 |
| An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation (NCT06466486) | Ferring Pharmaceuticals | 2024-06-14 |
| To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2 (NCT06378242) | RemeGen Co., Ltd. | 2024-06-14 |
| A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant (NCT06461039) | Novo Nordisk A/S | 2024-06-14 |
| HL-300 Ointment in Healthy Volunteers (NCT07684937) | Hangzhou Highlightll Pharmaceutical Co., Ltd | 2024-06-14 |
| A Clinical Study Investigating OM-85-IN Safety and Tolerability in Healthy Volunteers and Mild Allergic Asthma Patients (NCT06486662) | OM Pharma SA | 2024-06-14 |
| CBD for Knee Osteoarthritis (NCT06414473) | University of Florida | 2024-06-14 |
| A Study to Investigate Safety, Tolerability, PK and Anti-tumor Activity of TRX-221 in EGFRm NSCLC Patients (NCT06186076) | Therapex Co., Ltd | 2024-06-14 |
| To Evaluate the Safety of JL18008 (NCT07629310) | Jecho Biopharmaceuticals Co., Ltd. | 2024-06-13 |
| Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002) (NCT06829225) | Merck Sharp & Dohme LLC | 2024-06-13 |
| Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma (NCT06249191) | OHSU Knight Cancer Institute | 2024-06-13 |
| Safety and Tolerance of Increased Doses of HRS-5346 Tablets in Healthy Subjects (NCT06441227) | Shandong Suncadia Medicine Co., Ltd. | 2024-06-13 |
| Microbiome Alterations With Xylitol (MAX) in Pregnancy (NCT06329596) | Baylor College of Medicine | 2024-06-13 |
| A Study of Efinopegdutide in Healthy Obese Participants (MK-6024-015) (NCT06701305) | Merck Sharp & Dohme LLC | 2024-06-13 |
| A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers (NCT06082323) | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | 2024-06-13 |
| Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function (NCT06496217) | MBX Biosciences | 2024-06-13 |
| Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients (NCT06324604) | Mozart Therapeutics Australia Pty Ltd | 2024-06-13 |
| A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) (NCT06557265) | Nkarta, Inc. | 2024-06-13 |
| Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With T2DM (NCT07020949) | Tonghua Dongbao Pharmaceutical Co.,Ltd | 2024-06-13 |
| MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby) (NCT06455826) | PYC Therapeutics | 2024-06-13 |
| A Study of Diltiazem With a Single Dose of MK-6552 in Healthy Adult Participants (MK-6552-007) (NCT06662396) | Merck Sharp & Dohme LLC | 2024-06-13 |
| Study of APR-1051 in Patients With Advanced Solid Tumors (NCT06260514) | Aprea Therapeutics | 2024-06-13 |
| Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors (NCT06439589) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-06-12 |
| Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis (NCT06414135) | Liangjing Lu | 2024-06-12 |
| Mindfulness-Based Ecological Momentary Intervention For Smoking Cessation Among Cancer Survivors (NCT06476548) | H. Lee Moffitt Cancer Center and Research Institute | 2024-06-12 |
| Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients. (NCT06655662) | Shenzhen Hemogen | 2024-06-12 |
| Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors (NCT06239194) | ModeX Therapeutics, An OPKO Health Company | 2024-06-12 |
| Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin αvβ3 Positive Expression (NCT06375564) | The First Affiliated Hospital of Xiamen University | 2024-06-12 |
| Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2) (NCT06813365) | Dizal Pharmaceuticals | 2024-06-12 |
| FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC (NCT06303505) | Tubulis GmbH | 2024-06-12 |
| Phase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's Vaccine (NCT06831812) | Nuravax, Inc. | 2024-06-12 |
| Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study) (NCT05695495) | University Hospital, Basel, Switzerland | 2024-06-12 |
| AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy (NCT06063850) | UniQure Biopharma B.V. | 2024-06-12 |
| A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors (NCT06480240) | OBI Pharma, Inc | 2024-06-12 |
| Pilot Study of the Coronary Spur Stent for In-stent Restenosis (DEEPER CORONARY) (NCT06117150) | ReFlow Medical, Inc. | 2024-06-12 |
| DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia (NCT06382168) | Delta-Fly Pharma, Inc. | 2024-06-12 |
| Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers (NCT05691517) | National Cancer Institute (NCI) | 2024-06-12 |
| Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR) (NCT06467344) | Ascidian Therapeutics, Inc | 2024-06-11 |
| Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252 (NCT06126744) | Duke University | 2024-06-11 |
| Ziftomenib Maintenance Post Allo-HCT (NCT06440135) | Massachusetts General Hospital | 2024-06-11 |
| A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors (NCT06190886) | Proviva Therapeutics, Inc. | 2024-06-11 |
| Expansion of Virus-Specific Lymphocytes for Cell Therapy (NCT06011486) | Hospital Israelita Albert Einstein | 2024-06-10 |
| Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment (NCT06425198) | Bristol-Myers Squibb | 2024-06-10 |
| A Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Under Fasting Conditions (NCT06487416) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-06-10 |
| Rationale and Design of Diabetes Management With Curcumin and Saffron (DMCS): a Randomised, Three Blind -Blind, Placebo-controlled Study (NCT06413238) | Fateme Moshirenia | 2024-06-10 |
| A Study to Learn How the Study Medicine Called Zavegepant is Taken Up Into Blood and Breast Milk of Healthy Breast-Feeding Women (NCT06453356) | Pfizer | 2024-06-10 |
| Sintilimab Combined With LDRT for Neoadjuvant Treatment of Locally Advanced dMMR/MSI-H Gastric Cancer (NCT06426654) | West China Hospital | 2024-06-10 |
| Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-HCR21 and IY-MIC (NCT06471868) | Il-Yang Pharm. Co., Ltd. | 2024-06-10 |
| Multiple Dose, Bioequivalence Study of Generic Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets Under Fed Conditions (NCT06316336) | Pharma Nueva | 2024-06-10 |
| Safety of DNP007 in Healthy Subjects (NCT06400771) | Seoul National University Hospital | 2024-06-10 |
| A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Healthy Men and People With Overweight or Obesity (NCT06352437) | Boehringer Ingelheim | 2024-06-10 |
| Intra-articular Allocetra in Osteoarthritis of the 1st Carpo-metacarpal Joint (NCT06459063) | Kaplan Medical Center | 2024-06-10 |
| ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AML (NCT05622591) | Elucida Oncology | 2024-06-07 |
| Streptococcus Salivarius K12@Lip@GSH Alleviates Oral Mucositis in Patients Undergoing Radiotherapy (NCT06446180) | The General Hospital of Western Theater Command | 2024-06-07 |
| A Study of Psilocybin for PTSD (NCT06407635) | Johns Hopkins University | 2024-06-07 |
| Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case (NCT06813118) | HITEC-Institute of Medical Sciences | 2024-06-07 |
| A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma (NCT06425991) | Janssen Research & Development, LLC | 2024-06-07 |
| A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers (NCT06408948) | Jiangsu HengRui Medicine Co., Ltd. | 2024-06-07 |
| A First-In-Human Study of LY3985297 in Healthy Participants (NCT06395012) | Eli Lilly and Company | 2024-06-07 |
| Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors (NCT05687136) | National Cancer Institute (NCI) | 2024-06-07 |
| Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma (NCT06058663) | Mayo Clinic | 2024-06-06 |
| A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour (NCT06383871) | Shandong Suncadia Medicine Co., Ltd. | 2024-06-06 |
| NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NCT06402565) | NOxy Health Products, LLC | 2024-06-06 |
| A Study of SPY001-001 in Healthy Volunteers (NCT06448247) | Spyre Therapeutics, Inc. | 2024-06-06 |
| MAQ-001 in Patients With Advanced Solid Tumors (NCT06514651) | MabQuest SA | 2024-06-06 |
| The Remineralization of Early Enamel Caries in Permanent Teeth (NCT06358066) | Tanta University | 2024-06-06 |
| Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen (NCT06456892) | Sun Yat-sen University | 2024-06-06 |
| A Study in Healthy People to Compare How 2 Different Low Dose Formulations of BI 1015550 Are Taken up in the Body (NCT06408870) | Boehringer Ingelheim | 2024-06-06 |
| A Study to Learn About Whether BAY H006689 Causes an Allergic Reaction When Applied as a Topical Gel in Healthy Participants (NCT06415019) | Bayer | 2024-06-05 |
| A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1) (NCT06277219) | Latticon Antibody Therapeutics, Inc | 2024-06-05 |
| The Effect of GD-iExo-003 in Acute Ischemic Stroke (NCT06138210) | Xuanwu Hospital, Beijing | 2024-06-05 |
| Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease (NCT06270316) | UniQure Biopharma B.V. | 2024-06-05 |
| Pharmacokinetics, Pharmacodynamics Profile and Tolerance of HRS-9231 in Healthy Subjects (NCT07123376) | Shanghai Shengdi Pharmaceutical Co., Ltd | 2024-06-05 |
| Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer (NCT06102902) | National Cancer Institute (NCI) | 2024-06-05 |
| Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC (NCT06332755) | LG Chem | 2024-06-05 |
| A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors (NCT06336148) | Actym Therapeutics, Inc. | 2024-06-05 |
| Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis (NCT06097832) | Nexcella Inc. | 2024-06-05 |
| A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension (NCT06423352) | Alnylam Pharmaceuticals | 2024-06-05 |
| Anti-cancer DC Cell Vaccination to Treat Solid Tumors (NCT06477614) | Second Affiliated Hospital of Guangzhou Medical University | 2024-06-05 |
| Evaluation of Vamorolone Mineralocorticoid Receptor Antagonism in Healthy Subjects (NCT06649409) | Santhera Pharmaceuticals | 2024-06-05 |
| Single Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia® (NCT06310824) | Xentria, Inc. | 2024-06-05 |
| Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal Cancer (NCT06434090) | Sun Yat-sen University | 2024-06-05 |
| A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 Inclusive (NCT06433908) | GlaxoSmithKline | 2024-06-04 |
| Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer (NCT04887935) | Washington University School of Medicine | 2024-06-04 |
| Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC (NCT06064279) | VA Office of Research and Development | 2024-06-04 |
| A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS (NCT06372717) | Apollo Therapeutics Ltd | 2024-06-04 |
| Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder (NCT06086275) | Brigham and Women's Hospital | 2024-06-04 |
| A Clinical Study of YL205 in Patients With Advanced Solid Tumors (NCT06459973) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2024-06-04 |
| The Impact of Focused Ultrasound Thalamotomy of the Anterior Nucleus for Focal-Onset Epilepsy on Anxiety (NCT05032105) | Ohio State University | 2024-06-04 |
| Anti-cancer Neoantigen Polypeptide Vaccine to Treat Solid Tumors (NCT06195293) | Second Affiliated Hospital of Guangzhou Medical University | 2024-06-04 |
| Regenerative Treatment of Female Genital Atrophy (NCT07306611) | AndreiaAntunes | 2024-06-04 |
| A Study of Single and Multiple Doses HRS9531 Tablets in Healthy Subjects (NCT06435676) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2024-06-04 |
| Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator (NCT06233201) | Bio-innova Co., Ltd | 2024-06-04 |